NEONC TECHNOLOGIES HOLDINGS, INC.

Profile

Company Names

NEONC TECHNOLOGIES HOLDINGS, INC.

Addresses

23975 PARK SORRENTO, SUITE 205, CALABASAS, CA 91302

2 DOLE DRIVE, WESTLAKE VILLAGE, CA 91362

8335 SUNSET BOULEVARD, SUITE 240, LOS ANGELES, CA 90069

Phone Numbers

310 663 7831

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2023

State Incorporated:

DELAWARE

Total Amount Raised:

$126,607,120.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2026-06-10 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
6
2026-01-29 
$10,621,804.00 
$36,000,000.00 
$25,378,196.00 
Equity 
5
2025-12-01 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
4
2025-03-26 
$1,644,000.00 
$2,000,000.00 
$356,000.00 
Equity 
3
2025-03-10 
$9,999,984.00 
$10,000,000.00 
$16.00 
Equity 
2
2024-07-15 
$18,341,332.00 
$18,688,064.00 
$346,732.00 
Equity 
1
2023-04-07 
$80,000,000.00 
$80,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BADER 
 
ALMONAWER 
DIRECTOR
THOMAS 
CHEN 
EXECUTIVE OFFICER, DIRECTOR
ALAN 
 
CHIANG 
DIRECTOR
MING-FU 
 
CHIANG 
DIRECTOR
MING-FU (ALAN) 
 
CHIANG 
DIRECTOR
JIM 
 
DELSHAD 
DIRECTOR
KEITHLY 
 
GARNETT 
EXECUTIVE OFFICER, DIRECTOR
STEVEN 
 
GIANNOTTA 
DIRECTOR
STEVEN 
L. 
GIANNOTTA 
DIRECTOR
AMIR 
 
HESHMATPOUR 
EXECUTIVE OFFICER, DIRECTOR
AMIR 
F. 
HESHMATPOUR 
EXECUTIVE OFFICER, DIRECTOR
VICTORIA 
 
MEDVEC 
DIRECTOR
YOUSHA 
 
NEMAN-EBRAHIM 
EXECUTIVE OFFICER
ISHWAR 
KANWAR 
PURI 
DIRECTOR
PATRICK 
 
WALTERS 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-06-10 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-01-29 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-12-01 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-03-26 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-03-10 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-07-15 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-04-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
DAWSON JAMES SECURITIES, INC.